Cargando…

A Novel Inflammation-Based Stage (I Stage) in Patients with Resectable Esophageal Squamous Cell Carcinoma

Background. Inflammation plays a key role in cancer. In the current study, we proposed a novel inflammation-based stage, named I stage, for patients with resectable esophageal squamous cell carcinoma (ESCC). Methods. Three hundred and twenty-three patients with resectable ESCC were enrolled in the c...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Peng-Cheng, Feng, Ji-Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2016
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861804/ https://www.ncbi.nlm.nih.gov/pubmed/27212808 http://dx.doi.org/10.1155/2016/5396747

Ejemplares similares

Surgically resected T1‐ and T2‐stage esophageal squamous cell carcinoma: T and N staging performance of EUS and PET/CT
por: Jeong, Dong Young, et al.
Publicado: (2018)

Endoscopic Resection for Early-Stage Esophageal Cancer, Are We There for Squamous As Well?
por: Shah, Rushikesh, et al.
Publicado: (2017)

Heterogeneity of T3 stage esophageal squamous cell carcinoma in different parts based on enhanced CT radiomics
por: Li, Xiao-feng, et al.
Publicado: (2020)

A novel inflammation-based prognostic index for patients with esophageal squamous cell carcinoma: neutrophil lymphocyte ratio/albumin ratio
por: Zhao, Qiang, et al.
Publicado: (2017)

The Role of Adjuvant Chemoradiotherapy Over Radiotherapy After R0 Resection for Stage II-III Esophageal Squamous Cell Carcinoma
por: Song, Tao, et al.
Publicado: (2020)

A new inflammation index is useful for patients with esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2014)

Segmentectomy or Wedge Resection in Stage IA Lung Squamous Cell Carcinoma and Adenocarcinoma?
por: Li, Guoshu, et al.
Publicado: (2021)

A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma
por: Li, Jian-Pei, et al.
Publicado: (2016)

Endoscopic Resection for Synchronous Esophageal Squamous Cell Carcinoma and Gastric Adenocarcinoma in Early Stage Is a Possible Alternative to Surgery
por: Park, Se Jeong, et al.
Publicado: (2015)

Prognostic Significance of the Lung Immune Prognostic Index in Patients with Resected Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2021)

Prognostic Value of Plasma D-dimer in Patients with Resectable Esophageal Squamous Cell Carcinoma in China
por: Feng, Ji-Feng, et al.
Publicado: (2016)

Bronchial sleeve resection for early-stage squamous cell carcinoma
por: Goto, Taichiro, et al.
Publicado: (2012)

A novel inflammation-based prognostic score for patients with esophageal squamous cell carcinoma: the c-reactive protein/prognostic nutritional index ratio
por: Chen, Sheng, et al.
Publicado: (2016)

The Blood Oxygenation T(2)(*) Values of Resectable Esophageal Squamous Cell Carcinomas as Measured by 3T Magnetic Resonance Imaging: Association with Tumor Stage
por: Tang, Yu-lian, et al.
Publicado: (2017)

Applying post-neoadjuvant pathologic stage as prognostic tool in esophageal squamous cell carcinoma
por: Han, Weiming, et al.
Publicado: (2022)

Lymph node enlargement after definitive chemoradiotherapy for clinical stage I esophageal squamous cell carcinoma
por: Hayashi, Yoshito, et al.
Publicado: (2014)

Patterns of care and prognostic evaluation for stage I–III upper esophageal squamous cell carcinoma: a population-based study
por: Chen, Dongbo, et al.
Publicado: (2022)

Geriatric nutritional risk index as a prognostic marker of pTNM-stage I and II esophageal squamous cell carcinoma after curative resection
por: Hirahara, Noriyuki, et al.
Publicado: (2020)

Naples Prognostic Score: A Novel Prognostic Score in Predicting Cancer-Specific Survival in Patients With Resected Esophageal Squamous Cell Carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2021)

Laparoscopic Surgical Staging of Stage I Primary Squamous Cell Carcinoma of the Vagina
por: Childers, Joel M., et al.
Publicado: (1994)

Computed Tomography-Based Radiomics in Predicting T Stage and Length of Esophageal Squamous Cell Carcinoma
por: Yang, Mingwei, et al.
Publicado: (2021)

Survival based radiographic-grouping for esophageal squamous cell carcinoma may impact clinical T stage
por: Cai, Wenjie, et al.
Publicado: (2018)

A novel molecular and clinical staging model to predict survival for patients with esophageal squamous cell carcinoma
por: Wang, Wei, et al.
Publicado: (2016)

Lymphovascular invasion as an independent prognostic indicator in radically resected thoracic esophageal squamous cell carcinoma
por: Wang, Zhen, et al.
Publicado: (2018)

Tumor Stage-Based Gross Tumor Volume of Resectable Esophageal Squamous Cell Carcinoma Measured on CT: Association With Early Recurrence After Esophagectomy
por: Wu, Yu-ping, et al.
Publicado: (2021)

FDG PET/CT and Endoscopic Ultrasound for Preoperative T-Staging of Esophageal Squamous Cell Carcinoma
por: Huang, Yung-Cheng, et al.
Publicado: (2023)

A cost-effectiveness modeling study of treatment interventions for stage I to III esophageal squamous cell carcinoma
por: Daroudi, Rajabali, et al.
Publicado: (2022)

Prognostic value of lactate dehydrogenase to albumin ratio (LAR) in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2019)

The role of endoscopic tumor length in resected esophageal squamous cell carcinoma: a retrospective study
por: Chen, Peng, et al.
Publicado: (2021)

Upregulation of MAGEA4 correlates with poor prognosis in patients with early stage of esophageal squamous cell carcinoma
por: Tang, Wei-Wei, et al.
Publicado: (2016)

Optimal Range of Lymphadenectomy in Pathological Stage T1 and T2 Esophageal Squamous Cell Carcinoma
por: Wu, Hansheng, et al.
Publicado: (2021)

Gustave Roussy Immune Score (GRIm-Score) is a prognostic marker in patients with resectable esophageal squamous cell carcinoma
por: Feng, Ji-Feng, et al.
Publicado: (2020)

Preoperative lymphocyte-monocyte ratio is not an independent prognostic factor in M0 (stage I–III) esophageal squamous cell carcinomas
por: Chen, Chao, et al.
Publicado: (2020)

Additional Radiotherapy With or Without Chemotherapy Following Endoscopic Resection for Stage I Esophageal Carcinoma: A Pilot Study
por: Yang, Xu, et al.
Publicado: (2021)

Postoperative chemoradiotherapy improves survival in patients with stage II–III esophageal squamous cell carcinoma: An analysis of clinical outcomes
por: Zou, Bingwen, et al.
Publicado: (2016)

Efficacy of intensity-modulated radiotherapy for resected thoracic esophageal squamous cell carcinoma
por: Zhang, Wencheng, et al.
Publicado: (2015)

Practical value of identifying circulating tumor cells to evaluate esophageal squamous cell carcinoma staging and treatment efficacy
por: Chen, Weipeng, et al.
Publicado: (2018)

Survival outcomes for patients with four treatments in stages I–III esophageal squamous cell carcinoma: a SEER analysis
por: Wu, Jingyang, et al.
Publicado: (2021)

Prognostic biomarker study in patients with clinical stage I esophageal squamous cell carcinoma: JCOG0502‐A1
por: Oshima, Kotoe, et al.
Publicado: (2022)

Effectiveness evaluation of adjuvant concurrent chemoradiotherapy for patients with positron emission tomography‐staged esophageal squamous cell carcinoma after complete resection: A population‐based cohort study
por: Fang, Hsin‐Yuan, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_ushug6mflmjr5olc5mq8e9ekq2